Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

Introduction: O(6)-methylguanine-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase (IDH) mutation status are important prognostic factors for patients with glioblastoma. There are conflicting reports about a differential topographical distribution of glioblastoma with vs. wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Incekara, Fatih, van der Voort, Sebastian R., Dubbink, Hendrikus J., Atmodimedjo, Peggy N., Nandoe Tewarie, Rishi, Lycklama, Geert, Vincent, Arnaud J. P. E., Kros, Johan M., Klein, Stefan, van den Bent, Martin, Smits, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235346/
https://www.ncbi.nlm.nih.gov/pubmed/32477929
http://dx.doi.org/10.3389/fonc.2020.00596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235346/
https://www.ncbi.nlm.nih.gov/pubmed/32477929
http://dx.doi.org/10.3389/fonc.2020.00596

Ejemplares similares